13 analysts have shared their evaluations of GitLab GTLB during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 5 | 3 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 4 | 3 | 3 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $61.31, a high estimate of $80.00, and a low estimate of $50.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 10.85%.
Investigating Analyst Ratings: An Elaborate Study
The analysis of recent analyst actions sheds light on the perception of GitLab by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Matthew Hedberg | RBC Capital | Maintains | Outperform | $65.00 | $65.00 |
| Matthew Hedberg | RBC Capital | Maintains | Outperform | $65.00 | $65.00 |
| Kingsley Crane | Canaccord Genuity | Lowers | Buy | $65.00 | $74.00 |
| Gray Powell | BTIG | Lowers | Buy | $58.00 | $71.00 |
| Yi Fu Lee | Cantor Fitzgerald | Lowers | Overweight | $55.00 | $70.00 |
| Ryan McKeveny | Barclays | Lowers | Equal-Weight | $50.00 | $55.00 |
| Matthew Hedberg | RBC Capital | Lowers | Outperform | $65.00 | $74.00 |
| Pinjalim Bora | JP Morgan | Lowers | Neutral | $50.00 | $55.00 |
| Gil Luria | DA Davidson | Lowers | Neutral | $50.00 | $65.00 |
| Koji Ikeda | B of A Securities | Lowers | Buy | $80.00 | $85.00 |
| Gregg Moskowitz | Mizuho | Lowers | Buy | $62.00 | $70.00 |
| Jason Celino | Keybanc | Lowers | Overweight | $62.00 | $70.00 |
| Gregg Moskowitz | Mizuho | Lowers | Buy | $70.00 | $75.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to GitLab. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of GitLab compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of GitLab's stock. This comparison reveals trends in analysts' expectations over time.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into GitLab's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on GitLab analyst ratings.
Get to Know GitLab Better
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
Key Indicators: GitLab's Financial Health
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: GitLab displayed positive results in 3 months. As of 30 April, 2024, the company achieved a solid revenue growth rate of approximately 33.35%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: GitLab's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -32.3%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -9.59%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): GitLab's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -4.14%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: GitLab's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.0.
Analyst Ratings: Simplified
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
